European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Effects of a High-Prebiotic Diet versus Synbiotics on Mental Health April 7, 2023 The ‘old friends’ in your gut and how to care for them July 14, 2017 Synbiotics: The right match is everything March 24, 2022